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AbstrAct
Introduction A universal childhood influenza vaccination 
programme was introduced in the UK in September 2013. 
We examine the impact of the gradual introduction of this 
programme on influenza-related paediatric intensive care 
unit (PICU) admission rates in England.
Methods We extracted data on all influenza-related 
admissions to PICUs in England in resident children aged 
0–15 years old between October 2003 and March 2017 
from the Paediatric Intensive Care Audit Network (PICANet) 
database. We estimated influenza-associated PICU 
admission rates per 100 000 children by age group, sex 
and winter season (October to March), and used Poisson 
regression models to estimate incidence rate ratios (IRRs) 
in the winter seasons since the introduction of universal 
childhood vaccination compared with the two winters 
before the introduction of the programme (2011–2013).
results We identified 929 influenza-related PICU 
admissions among 873 children. 48.3% of admissions 
were among children aged less than 2 years old. The 
influenza-associated PICU admission rate was 1.32 per 
100 000 children (95% CI 1.23 to 1.40). We identified 
a significant increase in influenza PICU admissions in 
the winters following the introduction of the universal 
childhood vaccination programme compared with the 
winters of 2010/2011–2012/2013 among children aged 
<5 years old: IRR 1.58 (1.05, 2.37) in children <1 year, 
2.71 (1.43, 5.17) in 1 year-olds and 1.98 (1.18, 3.31) in 
children 2–4 years old. No significant difference was found 
among children aged 5–15 years.
conclusion The universal childhood influenza vaccination 
has not yet reduced the influenza-associated burden on 
PICUs in England during its early phase of introduction. 
Monitoring of influenza PICU admission rates needs to 
continue in England to assess the long-term impact 
of universal paediatric influenza vaccination. Linkage 
between PICANet and national infection surveillance 
databases would better enable such monitoring.
IntroductIon
Influenza can lead to severe disease in chil-
dren requiring admission to paediatric inten-
sive care units (PICU), as highlighted during 
the H1N1 influenza pandemic in 2009 and 
2010.1–3 Vaccination is the most effective 
method of preventing influenza infection,4 
and influenza vaccination has been found to 
reduce the risk of admission to intensive care 
units (ICU) in children aged 6 months and 
above in the USA.5 The UK introduced a new 
childhood influenza vaccination programme 
in September 2013, through which all chil-
dren aged 2–16 years old will be offered live 
attenuated influenza vaccine annually.6 The 
programme is being progressively rolled out, 
starting in September 2013 with children aged 
2 and 3 years old, who were offered vaccina-
tion in primary care. In England during the 
2016/2017 season, children aged 2–4 years 
were offered influenza vaccine in primary 
care, and school-age children up to age 8 were 
vaccinated through a school-based vaccina-
tion programme. The policy was introduced 
following a modelling study which predicted 
a reduction in influenza transmission leading 
to significantly reduced numbers of influenza 
infections and deaths in the population, even 
if only 30% of children aged 5–16 years are 
vaccinated annually.7 Prior to September 
Key messages
 ► Overall, less than 1% of paediatric intensive care 
unit (PICU) admissions in England between October 
and March were influenza related.
 ► Influenza-associated PICU admission rates have sig-
nificantly increased since universal paediatric vac-
cination was introduced in September 2013 among 
children less than 5 years old, compared with the 
two influenza seasons prior to introduction.
 ► This is the most comprehensive study to date of the 
impact of the introduction of the universal childhood 
influenza vaccination programme on PICUs in the UK.
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2013, only children aged 6 months to 2 years with chronic 
conditions at high risk for influenza complications were 
eligible to receive influenza vaccine. This targeted policy 
to high-risk groups remains for children aged 6 months 
to less than 2 years old, who are offered inactivated 
influenza vaccine.8 Although children aged less than 6 
months old are at highest risk of hospital admission due 
to influenza, there are no licensed vaccines for this age 
group. Instead, maternal vaccination during pregnancy 
was introduced in the UK in 2010 to protect pregnant 
women and newborn infants.9 
Influenza vaccination uptake among children in 
England is much lower than for other childhood vaccina-
tions. Between 2009 and 2016, uptake in children aged 
6 months to 2 years in high-risk groups remained below 
26%, and among children aged 2–15 years in high-risk 
groups uptake has remained below 50%.10 Uptake of 
influenza vaccination among older children through 
the universal programme is also relatively low: 38.1% of 
children of preschool age and 54.9% of 6 to  8-year-old 
children took up the offer of influenza vaccination in the 
winter of 2016/2017.10 11
Since prevention of severe influenza outcomes was 
one of the goals of introducing the universal childhood 
influenza vaccination programme, there is great interest 
in examining whether this programme is likely to relieve 
pressures on PICUs, particular during winter periods 
when demand on PICUs is higher.12 A previous evalua-
tion of the paediatric influenza vaccination programme 
in England conducted during the 2014/2015 season 
found no evidence of a statistically significant reduction 
in intensive care admissions due to influenza as a result of 
the introduction of a school-based influenza vaccination 
programme.13 However, this study compared ICU admis-
sion rates across selected areas of England in one influ-
enza season only. In this study, we used a national PICU 
database across 14 influenza seasons to assess differences 
in PICU admission rates before and after the introduction 
of the universal childhood influenza vaccine programme. 
Our aim was to examine whether the roll-out of universal 
childhood influenza vaccination to date has had an 
impact on influenza-associated admission rates to PICU.
Methods
We used data from the Paediatric Intensive Care Audit 
Network (PICANet), a national clinical audit database 
containing data on all children admitted to a PICU in 
the UK and the Republic of Ireland.14 We extracted 
data on all English resident children aged less than 16 
years old admitted to PICUs in England with influenza, 
between October 2003 and March 2017. Diagnostic infor-
mation in PICANet is entered by staff in each reporting 
PICU using Clinical Terms 3 (the Read codes, a clinical 
coding system originally developed for use in UK primary 
care15), based on information recorded in the children’s 
medical notes. Influenza-related admissions were identi-
fied as an admission where an influenza-associated Read 
code had been recorded as either the primary, secondary 
or comorbidity diagnosis.16 Note that the Read codes are 
selected by PICU staff responsible for data entry, and it is 
not possible to determine whether a child has laborato-
ry-confirmed influenza infection based on the Read code. 
Therefore, admissions were defined as influenza related 
based on diagnostic coding alone.
If multiple admissions occurred for the same child 
within 12 hours, we included only the first of these admis-
sions. This is to allow for children being discharged 
and readmitted if they require surgery. Admissions for 
the same child with a 12-hour gap or longer between 
discharge and subsequent admission were assumed to be 
independent admissions. Denominator data were based 
on midyear population estimates for England obtained 
from the Office for National Statistics.17
We classified admissions according to sex and age 
group, coded as <1 year, 1 year, 2–4 and 5–15 years, 
following the age groups delineating eligibility for the 
paediatric influenza vaccination programme. Chil-
dren with missing information on sex or age group 
were excluded from the analyses. We did not subdivide 
the <1 year age group since the population denomina-
tors were only available for single years of age, and this 
group therefore included children aged between 0 and 
11 months inclusive. We examined influenza-related 
PICU admission rates during winter periods, where a 
winter period was defined as first of October in year x to 
end of March in year x+1.
We defined five time periods to examine differences 
in PICU admission rates: October 2003 to March 2009 
(prepandemic period), October 2009 to March 2010 
(influenza A(H1N1)pdm2009 pandemic wave 2), 
October 2010 to March 2011 (pandemic wave 3), October 
2011 to March 2013 (postpandemic period) and October 
2013 to March 2017 (roll-out of universal childhood 
influenza vaccination programme). Years were grouped 
to reduce the effect of annual variations in influenza-re-
lated PICU admission rates.
We defined the presence of a high-risk chronic condi-
tion (and therefore eligibility for influenza vaccination 
under the targeted programme), using a previously 
published Read code list.18 We searched for the relevant 
Read codes during the PICANet admission. The condi-
tions were classified into six groups: neurological, respi-
ratory, cardiovascular conditions, immunodeficiency, 
kidney conditions or diabetes, and liver conditions or 
obesity. As for influenza diagnoses, chronic conditions 
are entered by PICU staff based on information on chil-
dren’s clinical notes, and a previous study has shown that 
chronic conditions are under-reported in PICANet.16
We calculated the proportion of total PICU admis-
sions related to influenza during winter periods, and 
the proportion of admitted children who had high-risk 
conditions. We estimated influenza PICU admission rates 
per 100 000 children by age group, sex and winter period 
with 95% CIs. The child population at risk in each winter 
period was estimated as
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MYEyear x + MYEyear x+1
)
  
where MYE is the midyear population estimates in 
a particular age group. We fitted Poisson regression 
models with counts of PICU admissions as the outcome 
variable and population size as the offset to examine 
risk factors for influenza-related PICU admission during 
winter seasons, and assess whether the introduction of 
universal influenza vaccination for children reduced 
admission rates. The regression model allowed us to 
estimate incidence rate ratios (IRR) by time period, 
using the two postpandemic seasons (2011/2012 and 
2012/2013) as the baseline period. We included age 
group, sex and time period as the exposure variables 
in the model a priori. We then added effect modifier 
terms between age group and time period to examine 
whether differences in admission rates by period (ie, 
the IRRs) differed by age group. Likelihood ratio 
(LR) tests were used to examine whether inclusion 
of the time period:age group effect modifier terms 
significantly improved the fit of the statistical model. 
An LR test p value <0.05 comparing a model with and 
without the effect modifier terms was seen to indicate 
a statistically significant improvement in model fit. We 
used Stata V.1419 for statistical analyses.
ethIcAl ApprovAl
Collection of personally identifiable data has been 
approved by the Patient Information Advisory Group 
(now the NHS Health Research Authority Confidenti-
ality Advisory Group (CAG)), see http://www. hra. nhs. 
uk/ documents/ 2017/ 04/ cag- piag- register- march- 2017. 
xls. The CAG and ethics approvals cover linkage between 
PICANet and other databases, including Hospital 
Episode Statistics.
results
We included 929 influenza-related admissions in 873 chil-
dren admitted to 28 PICUs in the winter seasons between 
October 2003 and March 2017. Of the 873 children, 829 
(95.0%) had one influenza-related admission, 35 (4.0%) 
had two, and 9 children (1.0%) had three or more 
influenza-related PICU admissions. The influenza-re-
lated admissions accounted for 0.9% of the total PICU 
admissions during these periods. The proportion of total 
PICU admissions accounted for by influenza-associated 
admissions varied between 0.3% in the winters between 
2004/2005 and 2006/2007 and 2.7% in the winter of 
2010/2011.
Table 1 shows the child characteristics for the 929 
admissions. Children aged 6 months or older who had 
high-risk conditions that would make them eligible to 
receive influenza vaccination under the targeted vacci-
nation programme accounted for 414 influenza-related 
admissions (44.6%). Neurological conditions were the 
most common type of high-risk condition, present in 
children for 302 admissions (32.5%). A total of 449 
admissions (48.3%) were in children aged <2 years who 
would not be eligible to receive influenza vaccination 
through the new universal paediatric influenza vacci-
nation programme (table 1), and 213 of the 929 admis-
sions (22.9%) were in children less than 6 months old.
The influenza-associated PICU admission rate during 
the 14 winters of the study period was 1.32/100 000 
children (95% CI 1.23 to 1.40). There was substantial 
variability between winter seasons in influenza-related 
PICU admission rates (figure 1). Rates peaked in the 
2010/2011 winter in children aged less than 5 years, and 
in the 2009/2010 seasons in children aged 5–15 years. 
Boys had higher admission rates than girls: 1.45/100 000 
children (1.32, 1.57) compared with 1.18/100 000 chil-
dren (1.07, 1.30), respectively. Admission rates were 
highest among children aged <1 year old (6.70; 5.97, 
7.49) and decreased with increasing age: 3.15/100 000 
children (2.66, 3.72) in children aged 1 year; 1.36 (1.17, 
1.58) in children aged 2–4 years; and 0.62 (0.55, 0.69) in 
children aged 5–15 years.
We identified significant (LR test P=0.001) effect 
modification between age group and time period on 
Table 1 Number and percentage of influenza-related 







  Male 521 (56.1)
  Female 406 (43.7)
  Missing 2 (0.2)
Age group (years)
  <1 306 (32.9)
  1 143 (15.4)
  2–4 183 (19.7)
  5–15 297 (32.0)
High-risk conditions present
  No 451 (48.5)
  Yes 478 (51.5)
Time period
  October 2003 to March 2009
  (prepandemic period)
161 (17.3)
  October 2009 to March 2010
  (influenza A(H1N1)pdm2009 pandemic 
wave 2)
152 (16.4)
  October 2010 to March 2011
  (pandemic wave 3)
208 (22.4)
  October 2011 to March 2013
  (postpandemic period)
90 (9.7)
  October 2013 to March 2017
  (roll-out of universal childhood influenza 
vaccination programme)
318 (34.2)
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admission rates, thus the age:time period effect modifier 
terms were included in the regression model. Children 
aged 5–15 years, unlike children aged less than 5 years 
old, had significantly lower influenza-related PICU 
admission rates in the prepandemic period than in the 
postpandemic period (table 2). In addition, admission 
rates peaked during the second pandemic wave among 
children aged 5–15 years, but during the third pandemic 
wave for younger children.
We did not identify a significant decrease in admis-
sion rates in the period since the introduction of the 
universal paediatric influenza vaccination programme 
Figure 1 Influenza-related PICU admission rates (per 100 000 children) by age group, sex and winter season*.
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compared with the two postpandemic winters in any age 
group (table 2). Instead, admission rates were signifi-
cantly higher in the four seasons since the introduction 
of universal paediatric influenza vaccination in 2013 
compared with the two immediate postpandemic seasons 
for children aged less than 5 years old. The IRR was not 
significantly increased in the period since October 2013 
compared with the two postpandemic winters in children 
aged 5–15 years old.
dIscussIon
We did not find evidence that the rate of influenza-re-
lated PICU admissions has declined during the first 
four seasons of the roll-out of the universal childhood 
influenza vaccination programme in England. Among 
children aged less than 5 years old, we found that influ-
enza-related admission rates to PICU were significantly 
increased in the seasons since the introduction of the 
programme compared with the winters of 2010/2011 and 
2012/2013. Throughout the study period, influenza-re-
lated PICU admission rates were highest among children 
aged less than 2 years old, who are not eligible to receive 
influenza vaccination through the universal childhood 
vaccination programme.
This study included all children admitted to a PICU in 
England with a diagnosis of influenza recorded during a 
14-year period. The use of a database covering all PICU 
admissions in England allowed population-based rates to 
be calculated. Since influenza-related PICU admissions 
are rare, national data collection is required for timely 
monitoring of the impact of universal vaccination on 
PICU admissions.
We did not have access to data on laboratory confir-
mation of influenza infection in this study, and instead 
relied on diagnostic coding of influenza to identify cases. 
Diagnostic coding for influenza in hospital databases 
has been found to have low sensitivity.20 Therefore, we 
are likely to underestimate the number of influenza-re-
lated admissions to PICU. However, our results are valid 
as long as the underascertainment is relatively constant 
over time (see below). We note that the average number 
of PICU admissions in children aged 0–14 years in this 
study between weeks 40 and 12 in the 2013/2014 to the 
2016/2017 influenza seasons is generally lower than 
the number reported through the UK Severe Influ-
enza Surveillance Scheme (USISS) to Public Health 
England.21–24 This scheme requires hospitals in England 
to report all laboratory-confirmed influenza cases 
admitted to higher dependency or ICUs.25 Unlike the 
USISS, our study does not include children admitted to 
high dependency units, which may explain the difference 
in reported admissions.
In addition, there is no standardised testing protocol 
for children with symptoms of respiratory infections who 
present to secondary care in the English NHS. There-
fore, not all children admitted to PICU with influenza 
infection would have a laboratory-confirmed diagnosis. 
Further, both laboratory testing practices and recogni-
tion and coding of suspected or laboratory-confirmed 
influenza in children in PICANet are likely to vary 
over time. In particular, PICUs were specifically asked 
to report confirmed influenza H1N1 cases to PICANet 
during the H1N1 pandemic between June 2009 and 
March 2011. It is likely that similar testing practices have 
Table 2 Incidence rate ratios (IRR) with 95% CIs by 
gender, age group and time period*
Risk factor IRR (95% CI)
Sex
  Male 1 (baseline)
  Female 0.82 (0.72 to 0.93)
Age group and period† 
<1 year
  Prepandemic
  (October 2003 to March 2009)
0.77 (0.50 to 1.18)
  Pandemic wave 2
  (October 2009 to March 2010)
2.06 (1.25 to 3.39)
  Pandemic wave 3
  (October 2010 to March 2011)
5.51 (3.65 to 8.32)
  Postpandemic
  (October 2011 to March 2013)
1 (baseline)
  Universal paediatric influenza 
vaccination programme (October 
2013 to March 2017)
1.58 (1.05 to 2.37)
1 year
  Prepandemic 0.82 (0.40 to 1.67)
  Pandemic wave 2 3.56 (1.69 to 7.48)
  Pandemic wave 3 5.61 (2.81 to 11.2)
  Postpandemic 1 (baseline)
  Universal paediatric influenza 
vaccination programme
2.71 (1.43 to 5.17)
2–4 years
  Prepandemic 0.68 (0.38 to 1.21)
  Pandemic wave 2 2.80 (1.52 to 5.16)
  Pandemic wave 3 3.98 (2.26 to 7.03)
  Postpandemic 1 (baseline)
  Universal paediatric influenza 
vaccination programme
1.98 (1.18 to 3.31)
5–15 years
  Prepandemic 0.44 (0.27 to 0.70)
  Pandemic wave 2 5.18 (3.40 to 7.89)
  Pandemic wave 3 3.90 (2.51 to 6.05)
  Postpandemic 1 (baseline)
  Universal paediatric influenza 
vaccination programme
1.45 (0.96 to 2.19)
*The models exclude two children with missing sex information.
†The IRRs by period are presented for each age group separately 
since the age group:time period effect modification term 
significantly improved the fit of the model and was therefore 
included.
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remained in place since March 2011 in English hospitals. 
In our study, we used the two postpandemic seasons as 
the baseline for our statistical model to assess changes 
in admission rates. We deem that the changes in labora-
tory techniques and sampling practices are likely to be 
much smaller between seasons during the years following 
the pandemic compared with between the prepandemic 
and postpandemic periods. Linkage to laboratory surveil-
lance data from England on children tested for influenza 
would allow for validation of diagnostic coding of influ-
enza in PICANet. Linkage between hospital databases 
and national laboratory surveillance data for influenza 
and other respiratory viruses is already available for chil-
dren in Scotland.26 Further linkage to hospital admission 
records for all children in England would be required to 
examine whether changes in PICU admission thresholds 
explain some of the annual variation in influenza-related 
PICU admission rates since the H1N1 pandemic.
We did not have information about whether children 
had been vaccinated against influenza. These data are 
not collected in PICANet, and there is currently no 
national immunisation database in England that records 
influenza vaccination receipt in children across the 
childhood age range. We could therefore not assess what 
proportion of admitted children were vaccinated, and 
if this proportion had changed over time. Instead, we 
relied on comparing influenza-related PICU admission 
rates before and after the introduction of the universal 
childhood influenza vaccination programme. Regular 
reporting of the number of vaccinated children admitted 
in England to PICU with influenza through the Public 
Health England USISS system would provide data on the 
number of vaccine failures and PICU admissions poten-
tially preventable through vaccination.
A previous study of the impact of universal vaccina-
tion of schoolchildren in England did not find a statisti-
cally significant effect of vaccinating primary school-age 
children on influenza admissions.13 That study was based 
on comparing rates of laboratory-confirmed influenza 
ICU admissions by age between selected areas of England 
which had piloted different school-based influenza 
vaccination programmes (no school-based programme, 
primary school or secondary school-based programmes). 
The study was based on data for the 2014/2015 season 
only, and underlying differences in PICU admission 
rates between areas (not related to the influenza vacci-
nation programme) were not accounted for. In contrast, 
our study included all influenza-related PICU admis-
sions across England since 2003. Influenza-related PICU 
admission rates were low in the postpandemic period, 
and in particular the 2011/2012 season. Therefore, the 
significant increase in admission rates since the introduc-
tion of universal influenza vaccination for children may 
be explained by a low baseline rate.
We identified a significant increase in influenza-re-
lated PICU admission rates in England since the intro-
duction of the universal paediatric influenza vaccination 
programme in children aged less than 5 years old, and 
no significant change in children aged 5 years and over. 
Monitoring of influenza-associated PICU admission rates 
should continue as part of the evaluation of the universal 
childhood influenza vaccination programme as it is being 
rolled out. Linkage between PICANet, national infection 
surveillance and hospital admission databases would 
allow improved characterisation of the influenza burden 
on PICUs nationally.
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